Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease

The TaxUMAP atlas: Efficient display of large clinical microbiome data reveals ecological competition in protection against bacteremia

(2023) Jonas Schluter et al.   Cell Host & Microbe

Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4

(2023) Aitor Blanco-Míguez et al.   NATURE BIOTECHNOLOGY

Alarming Trends: Mortality from Alcoholic Cirrhosis in the United States

(2022) Orly Termeie et al.   AMERICAN JOURNAL OF MEDICINE

Dosing a synbiotic of human milk oligosaccharides and B. infantis leads to reversible engraftment in healthy adult microbiomes without antibiotics

(2022) Julie E. Button et al.   Cell Host & Microbe

Dietary Cholesterol‐Induced Gut Microbes Drive Nonalcoholic Fatty Liver Disease Pathogenesis in a Murine Model

(2022) Jake B. Hermanson et al.   FASEB JOURNAL

Bifidobacterium infantis treatment promotes weight gain in Bangladeshi infants with severe acute malnutrition

(2022) Michael J. Barratt et al.   Science Translational Medicine

Association of serum and fecal bile acid patterns with liver fibrosis in biopsy-proven nonalcoholic fatty liver disease: An observational study

(2022) Yuki Kasai et al.   Clinical and Translational Gastroenterology

Association of Serum Metabolites and Gut Microbiota at Hospital Admission With Nosocomial Infection Development in Patients with Cirrhosis

(2022) Jasmohan S. Bajaj et al.   LIVER TRANSPLANTATION

Acetate reprograms gut microbiota during alcohol consumption

(2022) Cameron Martino et al.   Nature Communications

Design, construction, and in vivo augmentation of a complex gut microbiome

(2022) Alice G. Cheng et al.   CELL

Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure

(2022) Matthew R. Stutz et al.   Nature Communications

Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction

(2021) Julia Leonhardt et al.   Cellular and Molecular Gastroenterology and Hepatology

Impact of Antibiotic Resistance Genes in Gut Microbiome of Patients With Cirrhosis

(2021) Amirhossein Shamsaddini et al.   GASTROENTEROLOGY

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome

(2021) Scott W. Biggins et al.   HEPATOLOGY

Sensitive protein alignments at tree-of-life scale using DIAMOND

(2021) Benjamin Buchfink et al.   NATURE METHODS

Bifidobacterium response to lactulose ingestion in the gut relies on a solute-binding protein-dependent ABC transporter

(2021) Keisuke Yoshida et al.   Communications Biology

Bifidobacteria-mediated immune system imprinting early in life

(2021) Bethany M. Henrick et al.   CELL

Microbiome Therapeutics for Hepatic Encephalopathy

(2021) Patricia Bloom et al.   JOURNAL OF HEPATOLOGY

The Evolving Challenge of Infections in Cirrhosis

(2021) Jasmohan S. Bajaj et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Dose Lactulose as a Prebiotic for Improved Gut Health and Enhanced Mineral Absorption

(2021) Tarkan Karakan et al.   Frontiers in Nutrition

Baveno VII – Renewing consensus in portal hypertension

(2021) Roberto de Franchis et al.   JOURNAL OF HEPATOLOGY

Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation

(2020) Sidhartha R. Sinha et al.   Cell Host & Microbe

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation

(2020) Jonathan U. Peled et al.   NEW ENGLAND JOURNAL OF MEDICINE

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

(2020) Sadaf G Sepanlou et al.   Lancet Gastroenterology & Hepatology

Bile acids associate with specific gut microbiota, low‐level alcohol consumption and liver fibrosis in patients with non‐alcoholic fatty liver disease

(2020) Leon A. Adams et al.   LIVER INTERNATIONAL

Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure

(2020) Florence Wong et al.   JOURNAL OF HEPATOLOGY

Shiga toxin-producing E. coli transmission via fecal microbiota transplant

(2020) Caroline Zellmer et al.   CLINICAL INFECTIOUS DISEASES

Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity

(2020) Wenjing Yang et al.   Nature Communications

Long-term Outcomes after Fecal Microbiota Transplant in Cirrhosis

(2019) Jasmohan S. Bajaj et al.   GASTROENTEROLOGY

A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

(2019) Cyrielle Caussy et al.   Nature Communications

Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis

(2019) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Epidemiology of chronic liver diseases in the USA in the past three decades

(2019) Zobair M Younossi et al.   GUT

Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis

(2019) Andrew M. Moon et al.   Clinical Gastroenterology and Hepatology

Lactulose Improves Cognition, Quality of Life and Gut Microbiota in Minimal Hepatic Encephalopathy: A Multi‐Center, Randomized Controlled Trial

(2019) Ji Yao Wang et al.   Journal of Digestive Diseases

Lactulose: Patient- and dose-dependent prebiotic properties in humans

(2019) Jakub Ruszkowski et al.   ANAEROBE

Bile acid metabolites control TH17 and Treg cell differentiation

(2019) Saiyu Hang et al.   NATURE

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

(2019) Yi Duan et al.   NATURE

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

(2019) Zachariah DeFilipp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients with Cirrhosis

(2018) Jasmohan S. Bajaj et al.   Clinical Gastroenterology and Hepatology

NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis

(2018) Jacqueline G. O'Leary et al.   HEPATOLOGY

The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

(2018) Vyara Matson et al.   SCIENCE

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide

(2018) Salvatore Piano et al.   GASTROENTEROLOGY

Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification

(2018) Matthew T. Sorbara et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

(2017) Jasmohan S. Bajaj et al.   HEPATOLOGY

Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia

(2017) Li Xue et al.   Scientific Reports

Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease

(2017) Veronika B. Dubinkina et al.   Microbiome

Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans

(2016) Tommi Vatanen et al.   CELL

Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta-analysis

(2016) Lise L. Gluud et al.   HEPATOLOGY

Lactulose Differently Modulates the Composition of Luminal and Mucosal Microbiota in C57BL/6J Mice

(2016) Bingyong Mao et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

The challenges of multi-drug-resistance in hepatology

(2016) Javier Fernández et al.   JOURNAL OF HEPATOLOGY

Treatment of Patients with Cirrhosis

(2016) Phillip S. Ge et al.   NEW ENGLAND JOURNAL OF MEDICINE

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis

(2016) Vishwadeep Ahluwalia et al.   Scientific Reports

Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study

(2016) Sanjay K. Patole et al.   PLoS One

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

(2016) Marialena Mouzaki et al.   PLoS One

MEGAHIT: an ultra-fast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph

(2015) Dinghua Li et al.   BIOINFORMATICS

Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

(2015) Brian C. Ferslew et al.   DIGESTIVE DISEASES AND SCIENCES

Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease

(2015) M Llopis et al.   GUT

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

(2015) A. Sivan et al.   SCIENCE

Trimmomatic: a flexible trimmer for Illumina sequence data

(2014) Anthony M. Bolger et al.   BIOINFORMATICS

Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

(2014) Radha K. Dhiman et al.   GASTROENTEROLOGY

Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver

(2014) Hendrik Vilstrup et al.   HEPATOLOGY

Alterations of the human gut microbiome in liver cirrhosis

(2014) Nan Qin et al.   NATURE

Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile

(2014) Charlie G. Buffie et al.   NATURE

Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity

(2014) Sophie Leclercq et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Altered profile of human gut microbiome is associated with cirrhosis and its complications

(2013) Jasmohan S. Bajaj et al.   JOURNAL OF HEPATOLOGY

Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation

(2013) Nicholas Arpaia et al.   NATURE

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

(2012) Jasmohan S. Bajaj et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

(2012) Ying Taur et al.   CLINICAL INFECTIOUS DISEASES

Systematic review and meta-analysis of randomized trials on probiotics for hepatic encephalopathy

(2012) Kathrine Holte et al.   HEPATOLOGY RESEARCH

A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy

(2012) Jasmohan S. Bajaj et al.   METABOLIC BRAIN DISEASE

Improved Detection of Bifidobacteria with Optimised 16S rRNA-Gene Based Pyrosequencing

(2012) Kathleen Sim et al.   PLoS One

Spontaneous bacterial peritonitis: recent guidelines and beyond

(2011) R Wiest et al.   GUT

Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model

(2011) Ren-ying Xu et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Bifidobacteria can protect from enteropathogenic infection through production of acetate

(2011) Shinji Fukuda et al.   NATURE

Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans

(2010) Carles Ubeda et al.   JOURNAL OF CLINICAL INVESTIGATION

Butyrate Enhances the Intestinal Barrier by Facilitating Tight Junction Assembly via Activation of AMP-Activated Protein Kinase in Caco-2 Cell Monolayers

(2009) Luying Peng et al.   JOURNAL OF NUTRITION